Portincasa P, Di Ciaula A, de Bari O, Garruti G, Palmieri V O, Wang D Q-H
a Department of Biomedical Sciences and Human Oncology, Clinica Medica "A. Murri" , University of Bari Medical School , Bari , Italy.
b Division of Internal Medicine , Hospital of Bisceglie , Bisceglie , Italy.
Expert Rev Gastroenterol Hepatol. 2016;10(1):93-112. doi: 10.1586/17474124.2016.1109445. Epub 2015 Nov 11.
The majority of gallstone patients remain asymptomatic; however, interest toward the gallstone disease is continuing because of the high worldwide prevalence and management costs and the development of gallstone symptoms and complications. For cholesterol gallstone disease, moreover, a strong link exists between this disease and highly prevalent metabolic disorders such as obesity, dyslipidemia, type 2 diabetes, hyperinsulinemia, hypertriglyceridemia and the metabolic syndrome. Information on the natural history as well as the diagnostic, surgical (mainly laparoscopic cholecystectomy) and medical tools available to facilitate adequate management of cholelithiasis and its complications are, therefore, crucial to prevent the negative outcomes of gallstone disease. Moreover, some risk factors for gallstone disease are modifiable and some preventive strategies have become necessary to reduce the onset and the severity of complications.
大多数胆结石患者没有症状;然而,由于全球胆结石疾病的高发病率、治疗成本以及胆结石症状和并发症的发展,人们对胆结石疾病的关注度持续存在。此外,对于胆固醇性胆结石疾病,这种疾病与肥胖、血脂异常、2型糖尿病、高胰岛素血症、高甘油三酯血症和代谢综合征等高度流行的代谢紊乱之间存在密切联系。因此,关于胆结石自然病程以及有助于胆结石及其并发症合理管理的诊断、手术(主要是腹腔镜胆囊切除术)和药物治疗手段的信息,对于预防胆结石疾病的不良后果至关重要。此外,胆结石疾病的一些危险因素是可以改变的,一些预防策略对于减少并发症的发生和严重程度已变得十分必要。